NAD+ has been shown to enhance endothelial cells by activating the SIRT1-induced release of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (FGF) from myocytes, thereby effectively preventing vascular ageing and reducing the risk factors for heart failure [149]. The gene discussed is VEGFA; the disease is heart failure.